Market news

Despite the sale, the insider still holds 205,000 shares worth $2.6 million.

The past six months have been a windfall for LifeStance Health Group’s shareholders. The company’s stock price has jumped 92.6%, hitting $12.58 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Detailed price information for Choice Hotels International (CHH-N) from The Globe and Mail including charting and trades.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at LifeStance Health Group (NASDAQ:LFST) and its peers.

LifeStance Health, Tutor Perini, News Corp., Everus Construction and HF Sinclair offer growth potential amid oil and inflation worries.

Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.

SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 22,250,000 shares of LifeStance’s common stock, par value $0.01 pe

SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 22,250,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $12.35 per share, pursuant to a shelf registration statement filed with th

LifeStance Health Group has delivered a very strong share price gain over the past year, while its valuation checks send mixed signals. The intrinsic value estimate from a Discounted Cash Flow (DCF) approach points to some upside, yet market multiples suggest the stock screens as expensive and the broader value score is low. Over the past year, LifeStance Health Group has returned about 137%, which puts extra focus on whether recent optimism already prices in much of the story. The long term...

LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced that management will present at the following upcoming investor conferences. 2026 Jefferies Healthcare Services and Technology ConferencePresenter: Ryan McGroarty, CFODate: Monday, September 14, 2026Location: 1 Hotel Nashville, Nashville, TNTime: 10:20 a.m. (Central Time)Moderated by: Jack Slevin 24th Annual Mor

Outpatient and home healthcare stocks gain from aging, digital care and AI, with LifeStance, Option Care, Aveanna and DaVita in focus.

LifeStance Health, NVIDIA, Valero, Comfort and National Vision have been highlighted in this Screen of The Week article.

Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.

LifeStance Health Foundation today announced it will award $100,000 to the American Foundation for Suicide Prevention (AFSP) to extend its ongoing partnership, helping support clinical research to advance suicide prevention strategies.

LifeStance Health posted a quarter that surpassed market expectations, driven primarily by strong clinician productivity and expansion in specialty services. Management credited the company’s ability to grow its clinician base and the adoption of digital workflow tools for the robust performance. CEO David Bourdon highlighted, “We continue to grow our clinician base now at over 8,500 clinicians as our value proposition continues to resonate.” The quarter benefited from improved operational effic

Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.

Low-leverage stocks like LifeStance Health, Tutor Perini, Valero Energy, SharkNinja and Lumentum offer resilience amid oil and geopolitical risks.

In early August 2026, LifeStance Health Group reported second-quarter results showing higher sales and a move to net profitability, raised its 2026 revenue outlook, and completed a US$97.19 million share repurchase while authorizing a new buyback program of up to US$100 million. Together with new guidance for third-quarter revenue and an expanded focus on clinician productivity and specialty services, these actions signal management’s emphasis on scaling operations while returning capital to...

LifeStance Health (LFST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

A LifeStance Health survey of 1,000 women experiencing perimenopause or menopause released today reveals this life stage carries an unexpected mental health toll, as one in three women (33%) report being unaware that perimenopause can cause mental health-related symptoms.

Detailed price information for Surgery Partners CS (SGRY-Q) from The Globe and Mail including charting and trades.

Revenue surged 26% as clinician productivity climbed and payer rates improved.

LifeStance Health Group Inc (LFST) delivers exceptional Q2 2026 results with record free cash flow and strategic investments in technology and specialty services.